International Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease
November 29, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage...